Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study

Ida Skarping, Daniel Förnvik, Uffe Heide-Jørgensen, Lisa Rydén, Sophia Zackrisson & Signe Borgquist
Neoadjuvant chemotherapy (NACT) is offered to an increasing number of breast cancer (BC) patients, and comprehensive monitoring of treatment response is of utmost importance. Several imaging modalities are available to follow tumor response, although likely to provide different clinical information. We aimed to examine the association between early radiological response by three conventional imaging modalities and pathological complete response (pCR). Further, we investigated the agreement between these modalities pre-, during, and post-NACT, and the accuracy...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.